SearchDictionaryMobileLogin

Blackening of a choroidal hemangioma after photodynamic therapy.

AbstractBACKGROUND: Photodynamic therapy has recently advanced to a first line treatment of symptomatic circumscribed choroidal hemangiomas. HISTORY AND SIGNS: A sixty-year-old male patient was referred with progressive visual loss in his left eye. Visual acuity measured 20/80 and fundus examination revealed a prominent red subretinal lesion superior to the fovea with adjacent pigment epithelial irregularities. Thickening of the central retina was seen on OCT imaging. Sonography revealed a dome-shaped lesion with a maximal thickness of 3.3 mm and high internal reflectivity. Combined fundus indocyanine green and fluorescein angiography showed early filling of large vessels within the tumor. THERAPY AND OUTCOME: The hemangioma was treated with verteporphin photodynamic therapy. Two days after treatment, with vision unchanged, fundus examination revealed blackening of the tumor. Two months later vision increased to 20/40 and the tumor area was atrophic and bright red with a slight hyperpigmented rim. Angiography revealed the disappearance of tumor vessels and choroidal hypoperfusion in the area of treatment. CONCLUSIONS: Choroidal hemangiomas may darken initially after photodynamic therapy. This is most probably caused by large coaguli within the voluminous lacuna-like blood-filled vessel system of the hemangioma that are induced by photothrombosis.
AuthorsM M Bosch, H Helbig (Affiliation: Department of Ophthalmology, University Hospital Zurich, Zurich, Switzerland. martina.boesch at usz.ch)
JournalKlinische Monatsblätter für Augenheilkunde (Klin Monatsbl Augenheilkd) Vol. 222 Issue 3 Pg. 258-60 (Mar 2005) ISSN: 0023-2165 Germany
PMID15785995 (Publication Type: Case Reports, Journal Article)
Topics
  • Atrophy
  • Choroid (pathology)
  • Choroid Neoplasms (diagnosis, drug therapy, pathology)
  • Fluorescein Angiography
  • Fundus Oculi
  • Hemangioma (diagnosis, drug therapy, pathology)
  • Hematoporphyrin Photoradiation
  • Humans
  • Male
  • Middle Aged
  • Ophthalmoscopy
  • Pigmentation Disorders (etiology)